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We have dedicated Nikola Škreb Symposium to the 
memory of an outstanding scientist, the founder of the 
Zagreb School of Mammalian Embryology and above all 
to a teacher that inspired many to dedicate themselves 
to science. Being a medical doctor himself, Nikola Škreb 
understood that the basic biological research is the very 
fundament of every progress in medicine.
In 1986., when professor Škreb was supposed to retire, 
his students and collaborators D. Solter, I. Damjanov, D. 
Šerman and A. Švajger organized a memorable conference 
„Developmental Origins of Neoplasia“ in Dubrovnik with 
participation of leading developmental biologists- from 
Spemann's collaborator Salome Gluecksohn-Waelsch to 
the future Nobel prize winner Martin Evans. This great 
occasion inspired us to organize Škreb Symposia at our 
School of Medicine in the memory of our teacher. In the 
first Škreb Symposium „Experimental Mammalian Em-
bryology at the Turn of the Century (2003), where Davor 
Solter, Ivan Damjanov and Anton Švajger presented their 
research, we were honoured especially by participation of 
Anne McLaren and Andzej Tarkowski, the winners of that 
year’s Japan Prize. Next Symposium was held in 2013. with 
Davor Solter, Barbara Knowles, Takashi Hiiragi, Rolf Kem-
ler, Azim Surani, Anne Ferguson-Smith, Siniša Volarević, 
Dinko Mitrečić and younger members of the Department 
of Medical Biology.
The third Symposium in 2018. is one of the activities of 
the project Regenerative and Reproductive Medicine - 
Exploring New Platforms and Potentials, supported by the 
European Union through the European Regional Develop-
ment Fund, Operational Programme Competitiveness and 
Cohesion, under grant agreement No. KK.01.1.1.01.0008, 
of the Center of Excellence on Reproductive and Regen-
erative Medicine, Research Unit on Reproduction and 
Development.
We hope that all participants will benefit from the interest-
ing program.
Prof. dr. sc. Floriana Bulić-Jakuš 
Prof. dr. sc. Davor Solter
Prof. dr. sc. Davor Ježek
Preface
Nikola Škreb (1920-1993) was born in Za-
greb. He graduated from the School of Medi-
cine in 1948. and stayed on as a researcher and 
teacher at the Department of Biology until the 
very end of his life. Nikola Škreb did pioneer-
ing research in mammalian developmental bi-
ology and with his collaborators made major 
discoveries in that field. First, based on experi-
ments with teratogenic agents (with Z. Frank, 
N. Bijelić, M. Mueller), he found out that „all 
or none“ effect upon the embryo is lost with 
the critical phase of mesoderm formation, 
leading to congenital anomalies. Next, togeth-
er with A. Švajger and B. Levak-Švajger, he 
discovered that the epiblast is the source of all 
three germ-layers. With D. Solter
 and I. Damjanov he found out that the mouse 
embryo gives rise to a malignant teratocarcinoma after trans-
plantation under the kidney capsule of the adult animal. He 
also investigated differential gene activity during mammalian 
embryogenesis with D. Šerman and possibili-
ties of in vitro cultivation at the critical phase 
of gastrulation with V. Crnek-Kunstelj, F. Bu-
lić-Jakuš, M. Vlahović, G. Jurić-Lekić. Profes-
sor Nikola Škreb was the Head of Department 
from 1970. till 1993. and also the head of 
University Institute of Biology from 1962. till 
1972. His research activities in mammalian 
embryology were supported by many domes-
tic and several international USA and WHO 
grants. He was elected to the Yugoslav Acade-
my of Sciences and Arts in Zagreb (1979), was 
the honorary member of the Croatian Medi-
cal Academy in Zagreb. He was awarded the 
„Ruđer Bošković Award“ for science (1970), 
and the State Award for his Scientific Life 
Work (1979). Professor Škreb was elected the 
first president of European Developmental Biology Organi-
zation (EDBO) in 1978. and served as the president of the 
Croatian Natural Science Society.
Nikola Škreb biography
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Controlling Early Mammalian 
Development
Davor Solter
Emeritus Max Planck Director, Germany
Visiting professor School of Medicine University of Zagreb, 
Croatia
Epigenetic state of each cell is crucial in determining its gene 
expression and consequently its phenotype. Changes in the 
epigenetic state of the genome are essential for normal develop-
ment. While gradual changes in epigenetic states occur through-
out development there are two crucial moments when massive 
reprogramming of the genome takes place: transition from 
somatic cells to primordial germ cells and in zygote, following 
fertilization, when the germ cell epigenome transits to somatic 
epigenome state. During those transitions a general DNA de-
methylation takes places, however, there are several components 
of the genome e.g. imprinted genes that need to be protected. 
TRIM28 is one of the components of the protective mecha-
nism and its absence during oogenesis leads to post-fertilization 
failure. Variations in failure phenotype suggest that, in absence of 
TRIM 28, epigenetic marks are randomly lost, and not replaced, 
from individual genes resulting in epigenetic chimerism. These 
results emphasize the importance of maintaining and protecting 
correct epigenetic state during mammalian development.
Role of  Early-life Exposures 
on Epigenome and Cancer 
Susceptibility in Childhood 
and Adulthood
Zdenko Herceg
Section of Mechanisms of Carcinogenesis, Epigenetics Group, 
International Agency for Research on Cancer (IARC), Lyon, 
France
There is growing evidence for the causal relationship between in 
utero and early- life exposures and increased risk of a wide range 
of human diseases, including cancer. Environmental agents and 
nutrients can produce important, stable, and, in some instances, 
transgenerational epigenetic alterations underlying changes in 
the phenotype, consistent with the ‘Developmental Origins of 
Health and Disease’ (DOHaD) hypothesis. Although causal 
relations have not been firmly established yet, the recent advance 
in epigenetics provides insight for the mechanisms of early life 
predisposition to child and adult disease risk. The levels and 
patterns of DNA methylation undergo dramatic changes during 
embryonic development, starting with a wave of a profound 
demethylation during the cleavage stage and followed by a 
widespread de novo methylation after embryo implantation 
stage. As these mechanisms operate in strictly defined stages of 
development, it is possible that these developmental periods 
(such as peri-conceptual period) represent particularly sensitive 
windows of vulnerability. Adaptive responses during in utero 
life may include epigenetic changes in different developmental 
pathways (such as production and expansion of somatic stem/
progenitor cells, metabolic changes, and production of and sen-
sitivity to hormones), a combination of which may alter normal 
development of tissues and organs. Our group has recently been 
involved in the studies aiming to test the hypothesis that epigen-
etic changes associated with childhood cancer risk and exposure 
to environmental/dietary/lifestyle factors during pregnancy can 
be identified in blood cells at birth, and that methylation chang-
es can serve as sensitive biomarkers in primary and secondary 
prevention of childhood cancer. I will discuss recent evidence 
from our group and other laboratories indicating that epigen-
etic changes may be evident at birth and thus could constitute 
powerful mechanism-based biomarkers that could be exploited 
in disease prevention and epigenetics-based therapy.
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ma in vitro and therapeutic 
agents
Floriana Bulić-Jakuš
Department of Medical Biology, School of Medicine University 
of Zagreb, Croatia
Scientific Center of Excellence for Reproductive and Regenera-
tive Medicine, Zagreb, Croatia
Embryos and tumors have many similarities because both 
depend on same developmental processes such as the growth, 
differentiation, and apoptosis. Therefore, agents used in treat-
ment of tumors also act as teratogens on the mammalian embryo 
developing in utero. In our defined biological system in vitro, we 
omit confounding influence of the maternal organism and screen 
for teratogenic agents in an alternative to in vivo animal experi-
ments. In this natural three dymensional biological system we are 
assesing the impact of various agents on gastrulation, the most 
critical phase of development. At the air-liquid interface, gas-
trulating rat embryo develops in an experimental teratoma-like 
tumor consisting of the main derivatives of the three germ-layers 
formed at that stage of development. Consequently, this system 
was also used to screen for therapeutic agents that may negatively 
influence tumor development. Our recent results with various 
hyperthermal regimes that negatively affected development of 
embryos/experimental teratomas, pointed to the pretreatment 
with an anti-heat shock therapy before the hyperthermal regime 
that completely destroys such a tumor. Recently, by the Fouriere 
transform infrared spectroscopy (FTIR) we discovered differ-
ences in metabolomes of spent media used during the 14-days 
in vitro culture with the antiepileptic valproate that also seem to 
reflect the developmental status of the embryo/teratoma. Results 
with a physical agent and an epigenetic drug speak in favor of 
our biological system in screening for teratogenic agents and for 
novel therapies of tumors.
Acknowledgments: This study was supported by Scientific Cen-
ter of Excellence for Reproductive and Regenerative Medicine, 
Republic of Croatia, and by the European Union through the 
European Regional Development Fund, under grant agreement 
No. KK.01.1.1.01.0008, project „Reproductive and Regenerative 
Medicine - Exploring New Platforms and Potentials.
Limb Bud Development and 
Teratogenesis: in vivo/in vi-
tro
Ana Katušić Bojanac
Department of Medical Biology, School of Medicine University 
of Zagreb, Croatia
Scientific Center of Excellence for Reproductive and Regenera-
tive Medicine, Zagreb, Croatia
Modern genetic and functional analysis of the mammalian limb 
development have started to reveal fast changes in functions of 
development-driven genes and regulatory hierarchies during de-
velopment. It is known that temporal and spatial interplay of the 
signaling centers instruct limb bud morphogenesis in a self- reg-
ulatory manner. This interplay can be interrupted by mutations 
and teratogens that disrupt progression of limb development 
most often by causing death of the early-specified progenitors, 
while their fate remains the same. Here the essentials of an in 
vitro 3D organ culture model of the limb bud development will 
be presented. Our system uses 13 and/or 14 days old limb buds 
which are microsurgically derived from rat embryos and cultured 
at an air-liquid interface from 3 to 14 days in serum-supple-
mented or chemically defined media. This system supports the 
viability of tissue, offering a variety of parameters to be moni-
tored in the screening processes: cell proliferation, cell and tissue 
differentiation, cell death, size and the shape of limb explants 
and chondrogenesis. The example of how these parameters serve 
in the toxicity testing of chemicals (5azacytidine) or physical 
agents (temperature) with teratogenic potential will be shown. 
These results will be compared to in vivo research with an antiox-
idant in limb bud teratogenesis caused by 5azaC. Moreover, an 
overall methylation analysis in both models was done to explore 
the differences in DNA methylation due to the cultivation con-
ditions and developmental stage. The results support the usage of 
this model to study processes of limb bud development.
Acknowledgments: This study was supported by Scientific Cen-
ter of Excellence for Reproductive and Regenerative Medicine, 
Republic of Croatia, and by the European Union through the 
European Regional Development Fund, under grant agreement 
No. KK.01.1.1.01.0008, project „Reproductive and Regenerative 
Medicine - Exploring New Platforms and Potentials.
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Testicular Germ Cell Tu-
mors: From Mice to Men
Nino Sinčić
Department of Medical Biology, School of Medicine University 
of Zagreb, Croatia
Scientific Center of Excellence for Reproductive and Regenera-
tive Medicine, Zagreb, Croatia
Testicular GERM cell tumors (TGCT) are rare malignancies, but 
in fact the most common in young men. Model-based predic-
tions warn that Europe will see a further 25% increased burden, 
especially in Croatia. In line with the escalating incidence, and in 
support of future patient management, empowering research on 
mouse TGCT models seems to be crucial. Indeed, experimental 
mouse teratocarcinoma (emTCa), obtained by transplanting 
gastrulating egg-cylinder under the kidney capsule of syngeneic 
mouse, provides an outstanding system to study early TGCT 
development. In the frame of eight weeks development, emTCa 
grows steadily for six weeks after which it vigorously increases its 
weight. This period coincides with a peak in PCNA expression as 
well as a temporary SCGB3A1 tumor suppressor gene hyper-
methylation. Stemness genes OCT3/4 and NANOG show be-
haviour that is rather more complex. NANOG experiences a rise 
in DNA methylation immediately, after which remains stably 
hypomethylated in comparison to testis. NANOG mRNA level 
stabilizes in the sixth week and appears negatively correlated with 
emTCa growth in the eighth week. On the contrary, OCT3/4 
shows constant rise in DNA methylation that overshadows 
that in testis, reaching a maximum again in the sixth week. 
This change in OCT3/4 DNA methylation corresponds to the 
mRNA level, and both negatively correlate with emTCa growth 
in the eighth week. By knocking down OCT3/4 and NANOG 
by short esiRNA treatment in vitro, expression of both genes was 
arrested and growth of tumours significantly inhibited. These 
data suggest that NANOG and OCT3/4 are indeed drivers of 
TGCT tumorigenesis and that their DNA methylation status 
could be exploited as a potential biomarker in identification of 
early TGCT.
Acknowledgments: This study was supported by Scientific Cen-
ter of Excellence for Reproductive and Regenerative Medicine, 
Republic of Croatia, and by the European Union through the 
European Regional Development Fund, under grant agreement 
No. KK.01.1.1.01.0008, project „Reproductive and Regenerative 
Medicine - Exploring New Platforms and Potentials.
Authentic vs. Imitation: 
Trophoblast vs. Tumor
Ljiljana Šerman, Valentina Karin-Kujundžić
Department of Medical Biology, School of Medicine University 
of Zagreb, Croatia
Scientific Center of Excellence for Reproductive and Regenera-
tive Medicine, Zagreb, Croatia
Because of their ability to rapidly proliferate, migrate and invade 
into maternal tissue, trophoblast cells are responsible for the 
pseudo-malignant nature of the ingrowing placenta and in many 
respects resemble malignant tumor cells. However, unlike patho-
logical malignant states, the proliferative, migratory and invasive 
potentials of the trophoblast are physiologically regulated as well 
as spatially and temporally limited to the uterus and early stage 
of pregnancy. Failure of these mechanisms is equally detrimental 
to reproduction as is the excessive trophoblast invasion, and only 
proper coordination between all these processes results in correct 
placental development and birth of a healthy child. Thus, insuf-
ficient invasiveness of the trophoblast may result in preeclampsia 
or in intrauterine growth restriction (IUGR), whereas inordinate 
invasion can lead to abnormal attachment of the placenta with 
uterine tissue layers (myometrium and perimetrium), resulting 
in placenta accreta, placenta increta or placenta percreta. In ad-
dition, uncontrolled trophoblast invasion may lead to a range of 
gestational trophoblastic diseases (GTD), including gestational 
trophoblastic neoplasia, as well as development of reproductive 
and somatic tumors with pronounced trophoblastic component. 
To address some of the questions regarding normal vs. patholog-
ical trophoblast behavior as well as the development of ovarian 
neoplasms, we started studying the signaling pathways import-
ant for normal embryonal development, first the Wnt signaling 
pathway and, more recently, the Hedgehog signaling pathway. 
We shall present our own results on analysis of invasive processes 
in trophoblast/placenta and tumor tissues, obtained as a part of 
the research at the Center of Excellence for Regenerative and 
Reproductive Medicine from 2014 until today.
Acknowledgments: This study was supported by Scientific Cen-
ter of Excellence for Reproductive and Regenerative Medicine, 
Republic of Croatia, and by the European Union through the 
European Regional Development Fund, under grant agreement 
No. KK.01.1.1.01.0008, project „Reproductive and Regenerative 
Medicine - Exploring New Platforms and Potentials.
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In Vivo Visualization of  De-
velopmental Markers in Eval-
uation of  Mouse Brain Re-
pair After Ischemic Lesion
Srećko Gajović
Department of Histology and Embryology, University of Zagreb 
School of Medicine, Croatia Laboratory for Regenerative Neuro-
science, Croatian Institute for Brain Reaserch School of Medi-
cine University of Zagreb, Croatia
Brain development is a dynamic period when neurons are born, 
differentiated, start their functional activities or being shed by 
process of apoptosis. In case of brain injury, as in stroke, it would 
be advantageous to invoke the developmental processes in order 
to repair the brain damage. However, the repair abilities of the 
brain are rather limited, hence the stroke is number one cause of 
disabilities in the developed countries. In vivo imaging in small 
animals is an important method to monitor and evaluate the 
processes which occur after ischemic injury achieved by middle 
cerebral artery occlusion (MCAO), being model of ischemic 
stroke in humans. The imaging modalities used in our imaging 
platform (GlowLab) are magnetic resonance imaging (MRI) and 
optical bioluminescence imaging (BLI). MRI provides insights 
in structural brain changes, while BLI visualises the expression of 
genetic markers in the brain providing molecular aspects of the 
brain response. For BLI we used a developmentally important 
marker Gap43, which is involved in axonal outgrowth, both in 
development and after brain injury. Our specific interest was 
interplay between neuroinflammation and brain repair. The 
inflammation was modulated by loss-of-function of Tlr2, hence 
Tlr2-mediated inflammation was missing in these animals. In 
vivo BLI of Gap43-expression showed the increased repair in the 
Tlr2-deficient mice. Still, the proper measurements of BLI-signal 
required normalization by MRI-measured stroke volume. The 
in vivo imaging was confirmed by Western-blot analysis of brain 
samples. The obtained results highlight the benefits of multi-
modal approach, and confirm the usefulness of developmental 
markers in evaluation of the brain repair.
Acknowledgments: This study was supported by EU European 
Regional Development Fund, Operational Programme Competi-
tiveness and Cohesion, grant agreement No.KK.01.1.1.01.0007, 
CoRE – Neuro, and by the Croatian Science Foundation under 
the project IP-06-2016-1892 (RepairStroke).
Multimodal imaging was done at Laboratory for Regenerative 
Neuroscience - GlowLab, University of Zagreb School of Medi-
cine.
Influence of  Hypoxia on Be-
havior of  Developing Neural 
Precursors
Dinko Mitrečić
Department of Histology and Embryology, University of Zagreb 
School of Medicine, Croatia Laboratory for Stem Cells, Croatian 
Institute for Brain Research, School of Medicine University of 
Zagreb, Croatia
To understand mechanisms which influence the fate of devel-
oping neural precursors is important because of at least two 
major reasons: their differentiation occurs during normal (and 
abnormal) neural tissue development and moreover, it brings 
direct implications in potential treatment of nervous tissue by 
using transplantation of neural precursors. One of the important 
questions, still bringing controversies is: If we transplant stem 
cells in the brain affected by hypoxia – do we want them to 
follow their usual differentiation path? Or do we want some-
thing specific for hypoxic environment? In this work we describe 
application of stem cell in experiments which aim to elucidate 
both pathological and regenerative chain of events caused by 
lack of oxygen in the nervous tissue. Here we present our results 
showing that transplantation of stem cells in the brain affected 
by ischemia significantly influences expression of genes linked 
to cell death. This explains at least part of the beneficial effects 
observed in preclinical and clinical trials testing stem cell - based 
therapies for perinatal ischemia and stroke. Application of neural 
stem cells, automated microscope for in vitro cell tracking and 
specialized software allowed us to observe and quantify set of 
parameters occurring during neurogenesis in hypoxic conditions. 
Discovery of specific molecular pathways involved in tissue 
response to hypoxia/ischemia represents an important milestone 
in the current research activities which aim to propose new ther-
apeutic targets for nervous tissue damaged by the lack of oxygen.
Acknowledgments: This study was supported by Reserch project 
IP-2016-06-9451 “Stem cells from human oral mucosa for 
treatment of brain ischemia “ financed by Croatian Science 
Foundation.
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Histone Variants H3 Essen-
tial Role in the Maintenance 
and Reprogramming of  the 
Epigenetic Memory Carried 
by H3K27me3
Frederic Berger
Gregor Mendel Institute of Molecular Plant Biology GmbH, 
Vienna, Austria
The epigenetic mark H3K27me3 controls spatial and temporal 
patterning throughout the flowering plant life cycle. The histone 
variant H3.1 is essential for the propagation of H3K27me3 
(Jiang and Berger, Science, 2017). Whether this mark is exten-
sively reprogrammed at any point in development has remained 
unclear. We show that H3K27me3 is selectively erased from 
sperm chromatin in Arabidopsis through a multi-layered mech-
anism, which includes the deposition of a sperm-specific histone 
H3 variant that is immune to methylation at lysine 27. Resetting 
of H3K27me3 also coincides with selective types of deposition 
of H3K4me3 in a manner that potentiates expression in mature 
sperm and at distinct phases of development after fertilization. 
In stark contrast to the global resetting of epigenetic marks in 
mammals, plants have evolved mechanism to selectively repro-
gram H3K27me3. This mechanism acts as an epigenetic timer to 
control gene expression during plant development.
The New Biomedicine
Barbara B. Knowles
Professor Emerituss, The Jackson Laboratory, USA
True success is not in learning but in the application of this 
knowledge to the benefit of mankind. The acquisition of basic 
scientific knowledge by scientists working in genetics, develop-
mental- cell- and molecular-biology, immunology and virology 
throughout the 20th century has led to its application in clinical 
problems in the 21st century. The technology to repair genet-
ic defects in pluripotent cells and to differentiate these cells 
into progenitors of healthy tissue is almost within our power. 
However, the application of this knowledge to living organisms 
using cells that can mutate and selectively evolve makes clinical 
application tricky, whilst social and ethical issues arising from the 
use of this new technology requires thought. Attention to trends 
in basic science research should make stem cell therapy applica-
ble to all.
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Human Testis: From Devel-
opment to Clinics
Davor Ježek
Department of Histology and Embryology, University of Zagreb 
School of Medicine, Croatia Department for Transfusion Med-
icine and Transplantation Biology, University Hospital Centre 
Zagreb, Croatia
Scientific Center of Excellence for Reproductive and Regenera-
tive Medicine, Zagreb, Croatia
The seminiferous epithelium consists of supporting somatic 
Sertoli cells and spermatogenic cells. Spermatogenic cells are 
engulfed by the Sertoli cells cytoplasm & membrane. The unique 
feature of the neighbouring Sertoli cells are tight junctions 
positioned at the end of their basolateral cell processes, thus 
dividing seminifeorus epithelium into two compartments: basal 
(with spermatogonia) and apical (adluminal or meiotic, with 
haploid spermatogenic cells predestined to became spermatozoa. 
During the development of the indifferent gonad, under the 
influence of Sry, the vast majority of pre-Sertoli cells are thought 
to migrate inside the mesenchyme of the genital ridge from the 
surface coelomic epithelium. Namely, the coelomic subpopula-
tions of cells that express steroidogenic factor-1 (Sf-1) are picked 
by delaminating signals of the underlying mesenchyme of the 
genital ridge. They differentiate into pre-Sertoli cells (that express 
fibroblast growth factor 9 /Fgf9/ and Sox 9 /Sry –related HMG 
box-9/) and become the chief organisers of sex cords. The expres-
sion of Sf1 is maintained in early Sertoli cells and Leydig cells. 
Under the influence of Sf1, Sertoli cells produce anti-Müllerian 
hormone (Amh), whereas Leydig cells produce foetal testoster-
one. Thus, Sertoli cells are crucial for the normal function of 
the adult testis and the development of the “male” genital ridge. 
The normal onset of spermatogenesis & spermiogenesis after the 
puberty enables the production of spermatozoa. Therefore, the 
testis can be a valuable source of male gametes during micro-
surgical techniques such as testicular sperm extraction (TESE), 
employed for the treatment of male infertility.
Acknowledgments: This study was supported by Scientific Cen-
ter of Excellence for Reproductive and Regenerative Medicine, 
Republic of Croatia, and by the European Union through the 
European Regional Development Fund, under grant agreement 
No. KK.01.1.1.01.0008, project „Reproductive and Regenerative 
Medicine - Exploring New Platforms and Potentials.
Using an IV Spermatogenesis 
Platform to Model Male Factor 
Infertility and to Develop Nov-
el Stem Cell-based therapies
Charles A. Easley
College of Public Health, University of Georgia, Athens, GA, 
USA
Spermatogenesis is a critical process that ensures transmission of 
the paternal genome to offspring during fertilization. However, 
there are a number of external factors that can affect spermato-
genesis even resulting in sterility. Recent studies have indicated 
that sperm parameters in Western males have sharply declined by 
as much as 50% over the last 40+ years. While the causes of this 
sharp decline are unknown, the overall data indicate that infer-
tility rates in Western men may be steadily increasing. To date, 
nearly 15% of couples worldwide experience infertility issues, 
with male contributing factors playing a role in over 30% of 
these cases. With infertility rates in men sharply rising, investiga-
tions need to be conducted into a) what factors are contributing 
to this rise in infertility and b) what therapies can be derived to 
treat male factor infertility. Here, we utilize a novel human in vi-
tro model of spermatogenesis to examine environmental impacts 
on male fertility. Additionally, we use a non-human primate in 
vitro model of spermatogenesis to highlight a novel therapeutic 
approach for treating male infertility in cases where men fail to 
produce functional gametes for IVF.
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Early Lung Epithelial Pro-
genitors Originating From 
Human Pluripotent Stem 
Cells
Aleš Hampl
Faculty of Medicine, Masaryk University, Brno, Czech Republic
International Clinical Research Center, St. Anne ́s University 
Hospital Brno, Czech Republic
Currently, it is a challenge to obtain sufficient numbers of prima-
ry lung epithelial progenitor cells that could possibly be used for 
therapy and/or tissue engineering applications. Here we describe 
the cells differentiated in vitro from human embryonic stem 
cells (hESC) that can be propagated for long-term in culture and 
most likely represent equivalent of early lung progenitors (ELEP) 
occurring in development. We have shown that these cells can 
be maintained in culture for a minimum of 65 passages without 
losing their key characteristics. ELEP maintain their population 
doubling time at an average of 26.5 hours and the activity of 
their telomerase holds at about 50% of that typical for undif-
ferentiated hESC. ELEP express high levels of anterior foregut 
marker SOX2 (also typical for self- renewing cells), marker of 
definitive endoderm SOX17, and marker of early lung epithelial 
lineage, thyroid transcription factor-1. As found by transmission 
EM, ELEP also possess morphological features of cells differ-
entiating towards airway epithelia, multivesicular and lamellar 
bodies. When induced to terminally differentiate, ELEP increase 
levels of FOXJ1 (ciliated cells), pro-surfactant protein B (alveolar 
epithelial cells), Club cell specific protein (Club cells), aqua-
porin A (type I pneumocytes), and surfactant proteins A and 
C (type I pneumocytes and Club cells). Under 3D conditions, 
differentiating ELEP then develop morphologies of alveolar- and 
airway-like structures.
Acknowledgments: Funded by Grant 16-31501A (Ministry of 
Health of the Czech Republic).
Novel Technology for Regen-
eration of  Bone Defects
Slobodan Vukičević
Laboratory for Mineralized Tissues, Center for Translational and 
Clinical Research, University of Zagreb School of Medicine, 
Croatia
Scientific Center of Excellence for Reproductive and Regenera-
tive Medicine, Zagreb, Croatia
We developed a novel Autologous Bone Graft Substitute (ABGS) that is 
composed of recombinant human BMP6 (rhBMP6) and Autologous 
Blood Coagulum (ABC). ABGS uses low doses of BMP6 as compared to 
BMP2
(InFuse®) and BMP7 (Ossigraft®) and devoid of animal derived colla-
gen, thus elicits little or no inflammation and immune responses. We 
performed safety and efficacy preclinical studies using Rabbit Ulna 
Segmental Defect model and Posterolateral Lumbar Spine Fusion models 
in Rabbits and Sheep. ABGS was examined by alone and in combination 
with allograft or synthetic ceramics, Compression Resistance Matrices 
(CRM) in spine fusion models. The results demonstrated that ABGS 
induced a robust bone formation that resulted in restoration of segmental 
defects and complete achieved fusion in between two transverse processes 
at bilateral lumbar spine sites. The successful preclinical studies allowed an 
approval to examine the safety and efficacy of ABGS in Phase I/II clinical 
studies in patients with a Distal Radius Fracture (DRF) and High Tibial 
Osteotomy (HTO). ABGS is fabricated to render a flexible and injectable 
implant ensuring the ease of use. In DRF studies, three groups of patients 
enrolled: standard of care, ABC alone and ABGS (ABC+rhBMP6). The 
ABGR device was formulated from 1 mL of ABC and 250 μg of rhB-
MP6, while placebo was formed from 1 mL of ABC. No measurable plas-
ma amounts of rhBMP6 were detected after 5 min to 7 days, or BMP6 
antibody after 13 weeks. In addition, no serious adverse effects (SAE) have 
been observed, including swelling, redness of the skin, edema, distant soft 
tissue ossification, pain or systemic side effects. The use of a small dose of 
rhBMP6 in ABC minimized the risk of side effects and antibody produc-
tion as reported for BMP2 and BMP7 in such safety studies using DRF 
patients. In patients with HTO, the weight bearing part of the knee was 
shifted from overloaded knee compartment to realign the knee pressure. A 
randomized, double blind, placebo controlled trial was conducted in two 
stages in 20 patients treated with 10 ml ABC containing placebo or 1 mg 
rhBMP6. Phase I included 6 patients and in Phase II the remaining 16 
patients were enrolled. No SAEs have been reported, and at 24 weeks of 
radiological follow up there were different patterns of bone healing within 
the osteotomy wedges observed. The radiographic scoring of x-ray and 
CT data showed an accelerated osteotomy healing as compared to placebo 
treated patients. Our clinical study is the first evidence that BMP6 is safe 
and effective in the bone metaphyseal compartment when directly admin-
istered inside the trabecular bone area as opposed to reported unwanted 
safety issues in BMP2 and BMP7 when used at trabecular surfaces. 
Evaluation of ABGS with a CRM is in progress using a randomized Phase 
II Posterolateral Lumbar Interbody Fusion (PLIF) clinical study.
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Autism Spectrum Disorder in 
Patients with Rare Diseases
Bobinec A, Ivankov AM, Kero M, Sansović I, Barišić I
Children’s Hospital Zagreb, School of Medicine University of 
Zagreb, Croatia
Scientific Center of Excellence for Reproductive and Regenera-
tive Medicine, Zagreb, Croatia
Autism Spectrum Disorder (ASD) is heterogeneous group of 
neurodevelopmental disorders defined by impaired social-com-
munication and presence of restricted and repetitive patterns of 
behavior. ASD has a strong genetic basis indicated by higher rec-
curence risk within affected families as well as the co-occurence 
with rare genetic syndromes. Objective of our research was clin-
ical and molecular analysis of ASD patients in order to identify 
rare disorders associated with copy number variants (CNVs). 
Study included 110 children with psychiatric diagnosis of ASD. 
Patient’s samples were analyzed using chromosomal microarray 
from Jan 2016 until Jan 2018. CMA analysis detected CNVs in 
21 of 110 patients studied. Pathogenic CNVs were found in 13 
patients (Group A) while in additional 8 patients we detected 
variants of unknown significance (VUS) (Group B). Genetic 
changes found among patients in Group A included: 1p36 dele-
tion (1), 2q33.1 deletion (1), 8p23.1 microdeletion (1), 15q11.2 
microdeletion (2), 15q11-q13 duplication (1), 15q13.3 mi-
crodeletion (1), 17p11.2 deletion (1), 22q11.21 microduplica-
tion (1) and 22q13.3 deletion (1). We also found small deletions 
associated with autism that affected region 2q21.1 (1) and genes 
CNTNAP2 (1), NRXN1 (1). All patients in Group B had du-
plications that ranged from 131Kb to 1.6Mb and affected genes/
regions are known to be involved in neuronal development. 
All these CNVs were inherited from healthy parents and their 
clinical significance is uncertain. Detailed clinical and diagnostic 
assessment should be performed in all patients presenting with 
ASD. CMA proved to be useful diagnostic tool in diagnosing 
rare genetic conditions in autistic patients.
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Epigenetic Biomarkers of  
Prostate Cancer (epiPro)
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This project includes two interconnected goals. The first is to 
establish a new Scientific Group for Research on Epigenetic 
Biomarkers, epiMark. Scientists gathered through epiMark are 
already active in studying male reproductive health and disease, 
therefore will contribute to the next general goal: studying po-
tential epigenetic biomarkers (EB) in liquid biopsies of patients 
diagnosed with prostate cancer (PCa). PCa is second in inci-
dence and third cause of cancer deaths in Croatia, with incidence 
rates steadily rising. Contrarily, Croatia records a fall in PCa 
research. With PSA being quite sensitive biomarker, but not spe-
cific for PCa, there is a need for developing new diagnostic tools. 
Our aim is to investigate microRNA and DNA methylation 
which may serve as potential EB for PCa risk and disease pro-
gression, and tools for differentiating PCa and benign prostate 
hyperplasia (BHP). According to recent findings, we chose a set 
of miRNAs and gene promoter regions believed to be associated 
with PC development and progression. The study will be con-
ducted on volunteers diagnosed with PCa and BHP within rou-
tine at Urology departments of UHC Zagreb and UHC Sestre 
milosrdnice. In seminal fluid and blood, profiles of genes DNA 
methylation within cfDNA will be identified by pyrosequencing, 
while expression of miRNA by qPCR and ddPCR. Epigenetic 
analysis of gene expression will be performed on patient cancer 
tissues as well. By comprehensible statistical analysis, we expect 
to identify potential EB of PCa in liquid biopsies
Acknowledgments: This study was supported by Instalation 
reserch project UIP-2017-05-8138 „Epigenetic biomarkers in 
prostate cancer“ financed by Croatian Science Foundation and 
cofinanced by School of Medicine University of Zagreb.
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pressing CCR2 are Expanded 
in Collagen-induced Arthritis 
and May Be Involved in Bone 
Resorption Intensity
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Kelava T1,2, Katavic V1,3, Lukač N1,3, Zrinski Petrović 
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Medicine University of Zagreb, Croatia 3 Department of Anato-
my, University of Zagreb School of Medicine, Zagreb, Croatia
Osteoclast progenitors (OCP) originate from the myeloid lineage 
and mature to osteoclasts, specialized bone resorbing cells, which 
mediate bone destruction under inflammatory conditions in 
rheumatoid arthritis (RA). We investigated frequencies and 
osteoclastogenic potential of OCP subpopulations in bone mar-
row of affected joints (BM) in collagen-induced arthritis (CIA), 
a mouse RA model. CIA development in C57BL/6 and DBA 
mice immunized with chicken type II collagen was confirmed 
by micro-CT, histology, and serum CTX levels. BM cells were 
immunophenotyped for hematopoietic markers and chemokine 
receptor expression. Sorted OCP subsets were cultured with 
M-CSF/RANKL and assessed for TRAP+ osteoclast number, 
proliferative response by CFSE, and in vitro migration poten-
tial using Transwell system with chemotactic gradient. Mice 
developing CIA were treated with methotrexate (2mg/kg) and 
CCR2 receptor antagonist (CRA) (4mg/kg) to assess effects on 
OCP frequency. Frequency of CD45+B220-CD3-NK1.1-Ly6G-
CD11b−/loCD115+ OCPs was significantly increased in CIA 
(54% vs. 26% in control), with specific expansion of the CCR2+ 
subset. Regarding the CCR2 expression level, the CCR2lo subset 
underwent more divisions and generated multinucleated TRAP+ 
osteoclasts more efficiently, whereas the CCR2hi subset gener-
ated osteoclasts only when cultured at high density. OCPs from 
CIA mice demonstrated significantly enhanced migration toward 
CCL2 gradient. Our preliminary results indicate that a com-
bined methotrexate/CRA treatment may affect the frequency of 
OCPs. OCP subpopulation expressing CCR2 may contribute to 
increased homing of OCPs to bone surfaces of inflamed joints. 
Therefore, inhibition of CCL2/CCR2 signaling presents a new 
therapeutic approach to reduce osteoclast activity in arthritis.
Impact of  Endocrine Disrup-
tors on Androgen and Estro-
gen Receptors During Intra-
uterine Brain Development
Fucic A1,3, Simic G2
1 Institute for Medical Research and Occupational Health, 
Zagreb, Croatia  2 Croatian Institute for Brain Research, School 
of Medicine University of Zagreb, Zagreb, Croatia 3 Scientific 
Center of Excellence for Reproductive and Regenerative Medi-
cine, Zagreb, Croatia
Transplacental exposure to endocrine disruptors (EDs) may im-
pair concentration, motor function, and language development, 
reduce IQ, and possibly induce autism. In addition to epigenetic 
modifications of DNA and noncoding RNAs, diverse exposure 
profiles and mixtures of EDs, such as heavy metals, plasticiz-
ers, coupled with estrogen (ER) and androgen receptors’ (AR) 
may trigger in the developing brain adverse pathways at much 
lower toxic levels than conventional. Disturbance of estrogen/
testosterone balance during early brain development may cause 
discordance of mitotic dynamic and maturation sequence during 
neuron migration crucial for building of complex brain architec-
ture. Subplate zone as a major site of synaptogenesis is a transient 
part of the human brain whose peak of activity is seen at 22-24 
gestational weeks (GW). The expression of aromatase in subplate 
zone starts around 16thGW but there is no data available on 
its possible alterations by EDs. As majority of environmental 
EDs are xenoestrogens it is important to stress that ER-alpha is 
detected in the cortex as early as during the 9thGW, with high 
expression in proliferating zones and the cortical plate. In an 
animal model is has been shown that bisphenol A disturbs levels 
of ER-alpha, accelerate neuronal differentiation and migration. 
Additionally, aromatase inhibitor cotinin increases testoster-
one levels and disturbs AR levels, which have crucial roles in 
hippocampal neurogenesis and corpus callosum development. 
It is hoped that prospective data integration by Systems Biology 
Graphical Notation using deep learning artificial intelligence 
could serve for real time investigation of complex EDs effects 
during intrauterine brain development.
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Molecular Analysis of RB1 
Gene Expression Dynamics 
During the Pluripotency Transi-
tion in the Mammalian Embryo
Himelreich Perić M, Katušić Bojanac A, Sinčić N, 
Bulić Jakuš F
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of Zagreb, Zagreb, Croatia Scientific Center of Excellence for 
Reproductive and Regenerative Medicine, Zagreb, Croatia
RB1, the retinoblastoma susceptibility gene is an important 
regulator of cell proliferation, apoptosis and differentiation. The 
RB protein shows an important function in the cell cycle by 
controlling the G1/S phase transition. In its hypophosphorylated 
form, RB is active and supresses the cell cycle progression, as 
it inactivates transcription factors (TFs), mostly from the E2F 
family. In G1, the formation of cyclinD/CDK4/6 complexes 
hyperphosphorylates the RB, causing its disability to bind E2F 
family members, which then leads to the progression to the S 
phase. Embryogenesis provides a system to investigate the roles 
of RB family proteins at the interface between proliferation and 
differentiation. The most compelling evidence of the importance 
of RB in cellular differentiation comes from studies of RB1 
knockout mice, where the disruptions of the RB1 gene cause 
death by day 14 of gestation, associated with defects in the devel-
opment of the hematopoietic system and central nervous system. 
Studies on immunohistochemical expression in the mouse and 
adult human showed a cell- specific heterogenous pattern in 
various tissues. RB is expressed in differentiated cells and is 
absent from cells that still proliferate (e.g. mouse retina, stratified 
squamous epithelium, and gut epithelium of the mouse, adult 
human cervical epithelium of the uterus). Methylation patterns 
for the retinoblastoma gene (RB1) in single human blastocysts 
showed 40%-60% methylation, indicating that a methylation 
imprint was present. Its hypermethylation also occurs in tumors, 
associated with RB1 gene disfunction. By using modern molecu-
lar methods (pyrosequencing, ddPCR) and immunohistochemis-
try, we shall try to determine yet unknown RB gene methylation 
and expression changes in transition from the pluripotency to 
the differentiated state in mammalian embryos.
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ter of Excellence for Reproductive and Regenerative Medicine, 
Republic of Croatia, and by the European Union through the 
European Regional Development Fund, under grant agreement 
No. KK.01.1.1.01.0008, project „Reproductive and Regenerative 
Medicine - Exploring New Platforms and Potentials
Preparation Protocols for 
Mouse Ischemic Brain Le-
sion Evaluation: Multimodal 
Approach
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Multimodal imaging and volumetric analysis of the mouse 
ischemic brain are used to evaluate potential neuroprotective 
therapies and to establish new therapeutical approaches during 
preclinical trials. When using several imaging techniques we can 
obtain more information and reduce the number of experimental 
animals, simultaneously allowing macroscopic and microscopic 
3D evaluation of the ischemic lesion evolution. C57Bl/6 albino 
mice underwent 60-minute cerebral ischemia induced by the 
middle cerebral artery occlusion method. The first two groups 
of animals underwent different fixation protocols: the Evap-
oration-of- Organic-Solvent (EOS) dehydration method for 
synchrotron imaging and hydration for MR imaging. The other 
two groups underwent different contrast agent staining proce-
dures using phosphotungstic acid or non-ionic iohexol monomer 
staining. Different fixation protocols influenced MRI quality and 
contrast of the visualized lesion, which was easily delineated by 
SRμCT imaging when the EOS method was applied. Contrast 
agents enabled better ischemic lesion visualization only for 
synchrotron and micro-CT imaging. Volumetric analysis of the 
ischemic lesion and brain oedema was clearly influenced by the 
preparation methods used, which differently affected the lesioned 
area and the healthy tissue, producing a huge variability in the 
measured volumetric values. MRI enables good gross morpholo-
gy visualization of the brain tissue, while micro-CT and SRμCT 
provide high resolution neuroarchitectonic depiction.
Acknowledgements: This work was supported by Croatian 
Science Foundation RepairStroke IP-06- 2016-1892 and by 
Synchrotron Light Source ‘Elettra’ grant n. 20170140 and n. 
20165273.
The MRI scans were performed at the Laboratory for Regenera-
tive Neuroscience – GlowLab, School of Medicine University of 
Zagreb, Croatia.
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Analysis of  c-KIT Expression 
in Nonseminomatous Testic-
ular Germ Cell Tumors
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Incidence of testicular germ cell tumors (TGCT) has been contin-
uously rising (1- 5% per year). (In Croatia the incidence of TGCT 
is increasing at the highest rate in the world. Croatia also has a 
high rate of mortality compared to other countries. Germ cell 
neoplasia in situ (GCNIS) is a precursor lesion of TGCT’s which 
makes up to 95% of all testicular tumors. TGCT are divided into 
pure seminomatous and non-seminomatous tumors. GCNIS is 
considered to be driven by an interplay of genetic, epigenetic and 
micro-environmental factors that lead up to an arrest of gonocyte 
differentiation. GCNIS is reprogrammed in the development of 
non- seminomas into embryonal carcinoma (EC) cells, which 
make up the pluripotent core of the non-seminomas. Currently 
used biomarkers for testicular cancer lack both specificity and 
sensitivity, and are used primarily as accessories in diagnostics. A 
deeper look into the molecular signature of nonseminomatous tu-
mors is needed, due to their often times aggressive progression and 
cisplatin resistance. The aim of this study is the analysis of protein 
expression in nonseminomatous tissue as a potential biomarker 
of nonseminoma development and progression. Formalin-fixed 
paraffin-embedded tissue from 43 nonseminomatous testicular 
tumors from the Ljudevit Jurak Pathology and Cytology De-
partment Archive, from the University Clinical Hospital Centre 
Sestre Milosrdnice, were used for immunohistochemical detection 
of c-KIT. Slides were analyzed semi-quantitatively, at the area of 
strongest reaction, by pathologist, on a scale from 0-3, depend-
ing on the percentage of reactive cells. The data was analyzed in 
GraphPad Prism using the Mann-Whitney test. The results have 
shown c-KIT staining in non-seminoma tissue to be comparable 
to healthy testis tissue. The intensity and positivity of c-KIT stain-
ing in non-seminoma is either fully absent, or if a “weak” signal 
is present it is mostly in the teratoma component. Germ cell neo-
plasia in situ (GCNIS) is c-KIT positive. The difference in c-KIT 
protein expression between GCNIS and teratoma versus other 
non-seminoma and healthy testis tissue opens ia question on the 
role of c-KIT in non-seminoma development and differentiation.
Acknowledgments: This study was supported by Scientific Center of Ex-
cellence for Reproductive and Regenerative Medicine, Republic of Croatia, 
and by the European Union through the European Regional Development 
Fund, under grant agreement No. KK.01.1.1.01.0008, project „Reproduc-
tive and Regenerative Medicine - Exploring New Platforms and Potentials
Molecular Analysis of  Ley-
dig Cells in Patients With 
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Non-obstructive azoospermia (NOA) is a severe diagnosis of 
male infertility characterized by the complete absence of sperm 
in the ejaculate with different level of spermatogenesis abnormal-
ities. Various histological anomalies have been detected in the 
testicular tissue biopsies of NOA patients such as deterioration of 
seminiferous tubules and belonging cells (germ cells, Sertoli cells) 
together with morphological changes of Leydig cells. Leydig cells 
are androgen producing cells located in the interstitial space, 
adjacent to seminiferous tubules and near blood capillaries. It 
has been demonstrated that Leydig cells within the same NOA 
patient may be considered mosaic. Part of the Leydig cell pop-
ulation may increase in size (hypertrophy) and number (hyper-
plasia) with 15 or more cells clustered together, another portion 
may contain extremely vacuolated cytoplasm while some Leydig 
cells produce testosterone in excess. Therefore, the aim of our 
research will be to elucidate the molecular profile behind Leydig 
cell morphological variations in NOA testes with normal testos-
terone production. Leydig cells will be analyzed by the presence 
of their hypertrophy, hyperplasia and vacuolization. Workflow 
will include isolation of Leydig cells with laser microdissection 
system, cell lysis and isolation of nucleic acids. Expression of 
genes implicated in steroidogenesis, synthesis of male andro-
gens, and proliferation will be analyzed on single cell level with 
ddPCR and/or qPCR. Single-cell sequencing methods will be 
also performed to study DNA methylation. Protein expression 
will be analyzed by immunohistochemistry. We expect to define 
set of genes which will explain the Leydig cell dysfunction and 
morphological changes in NOA patients.
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University Hospital for Tu-
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Genetic counselling unit exists as a separate functional unit in 
University hospital for tumours from the year 2015. It is based 
on cooperation and teamwork of experts of different profiles: 
medical geneticist, surgeons, oncologists, molecular geneticists, 
specialized nurses and psychologists. The aim is to recognize 
and counsel patients with family and personal history indica-
tive of the hereditary cancer syndrome. Most of the patients are 
those suspected to have hereditary breast and ovarian cancer 
syndrome, although there are also patients with familial adeno-
matous polyposis, Lynch syndrome (hereditary non-polyposis 
colorectal cancer syndrome), neurofibromatosis and few other 
very rare hereditary cancer syndromes (e.g. von Hippel-Lindau 
disease, Li Fraumeni). Clinical signs pointing to the possibility 
of pathogenic mutation in some of the predisposing genes (early 
age of onset, typical histology, multiple tumours...), along with 
confirmed family history are the base of selection. Patients with 
such disease characteristics are referred to a genetic counselling 
centre with the assessment of indication for further genetic 
testing. Genetic testing of hereditary breast and ovarian cancer 
syndrome (BRCA1 and BRCA2 genes), as the most commonly 
identified hereditary cancer, is now available and covered by 
Croatian health Insurance Fund through the programme of 
genetic counselling in an authorized institution. The analysis is 
performed by next generation sequencing technology coupled 
with quantitative polymerase chain reaction (qPCR) for detec-
tion of large deletions and duplications. The positive result is 
confirmed by Sanger sequencing. Genetic testing is performed in 
a Laboratory for hereditary cancer and Laboratory for advanced 
genomics at Rudjer Boskovic Institute, Zagreb. Patient receives 
genetic counselling before and after genetic testing. Primary and 
secondary prevention measures that could be undertaken after 
the results of hereditary breast cancer genetic testing in a high 
risk population contribute to savings in the health care system 
and the better quality of life in a group of high risk individuals.
Involvement of  Key Modula-
tors of  Wnt Signaling, sFRP1 
and sFRP3, Across Malig-
nancy Grades of  Human As-
trocytoma
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SFRP gene family code for important regulatory proteins of 
Wnt signaling usually limiting pathway’s activity. We investi-
gated the involvement of SFRP1 and SFRP3 in astrocytomas of 
different malignancy grades in order to better understand their 
behavior in tumor progression. The expression was analyzed by 
immunohistochemistry, digital scanning and image analysis. 
Promoter hypermethylation was examined with methylation-spe-
cific polymerase-chain- reaction. Our results demonstrate that 
hypermethylation of SFRP1 promoter was progressively rising 
in astrocytoma grades with the highest distribution in glioblas-
toma (P=0.042). Furthermore, cases with methylated promoter 
expressed significantly less SFRP1 than unmethylated ones 
(P=0.031). Pathway’s indicators of oncogenic activity, beta-cat-
enin, LEF1 and TCF1, were also explored. Glioblastomas with 
unmethylated SFRP1 promoter had significantly less beta- cat-
enin (P=0.033), while strong expression of both LEF1 and 
TCF1 was associated to higher astrocytoma grades (P=0.006). 
The results on SFRP3 involvement were not so straightforward 
demonstrating different behavior in subcellular compartments. 
Stronger nuclear expression values were associated with lower 
astrocytomas grades (P=0.028) as compared with astrocytoma 
grades III and IV. Contrary, stronger cytoplasmic expression 
levels were higher in the astrocytoma III and IV group than in 
the astrocytoma I and II group (P=0.048). Our findings show 
that SFRP1 gene behaves as a classical tumor suppressor and was 
significantly epigenetically silenced in glioblastomas as compared 
to low astrocytoma grades, suggesting its lack allows progression. 
SFRP3 protein demonstrated dual behavior as an antagonist of 
Wnt signaling when found in the nucleus, whereas when located 
in the cytoplasm as an agonist of Wnt signaling promoting 
invasive behavior.
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Testicular neoplasia represents only 1% of all neoplasia, but it af-
fects young male population. Approximately 95 % of all testicu-
lar cancers are germ cell tumors. There are two groups of TGCT, 
seminoma and non-seminoma. Compared to non– seminoma, 
seminoma is hypomethylated. The hypomethylated genome 
is unstable and more exposed to mutations what brings to the 
emergence of tumor cells. Hypomethylated genes show higher 
expression rate than other genes. Consequently, the gene ex-
pression pattern between tumor and healthy tissue differs. Gene 
expression on the protein level is used for diagnosis of tumors. 
OCT 3⁄4 is a gene which is already used as a specific marker for 
the diagnosis of seminoma, but new markers could contribute to 
diagnostic protocols and patient management. Archive semi-
noma slices were collected. Immunohistochemical staining was 
done manually, on 5μm archive tissue sections in the Laboratory 
for Epigenetics and Molecular Medicine. To visualize our genes 
of interest, we used specific antibodies. Morphometric analysis of 
gene expression at the protein level was performed at University 
Hospital Sestre Milosrdnice Department of Clinical Pathology 
Ljudevit Jurak. Differential gene expression in tumor tissue 
and in healthy tissue was observed. Analyzing and quantifying 
expression of genes at the protein level can contribute to the 
development of new histopathological markers for seminoma in 
blood and semen.
Acknowledgments: This study was supported by Reserch project 
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Science Foundation.
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Congenital anomalies (CA) encompass a wide array of structural 
and functional abnormalities that can occur in isolation, or can 
be associated with other anomalies and/or developmental prob-
lems. When CA are associated with additional clinical features 
(ACF), they often result from genetic defects or teratogenic 
factors. Copy number variants (CNVs) are among important 
causes of genetic syndromes associated with CA. Chromosomal 
microarray (CMA) is used as the first test to detect the CNVs in 
this category of patients. The aim of the study was to determine 
clinically relevant CNVs in 233 unrelated subjects analysed 
in the period between January 2016 and December 2017 in 
Children’s University Hospital Zagreb because of the presence of 
one or more CA and ACF. In addition, we have analysed a group 
of 70 patients with isolated congenital heart defects (CHD). All 
clinically relevant CNVs were compared with those reported 
in public genomic databases, and their clinical significance was 
evaluated. CNVs were detected in 96 (41.2%) patients. Patho-
genic variants were detected in 76 (79.2%) and VOUS in 20 
(22.3%) subjects. Clinically relevant CNVs were slightly more 
frequent in patients with multiple CA (48.0%) than in patients 
with single CA (35.9%) (p=0.0604). In the group of patients 
with isolated CHD two pathogenic deletions and three VOUS 
were detected resulting in the diagnostic yield of 7.1%. CMA 
has proven to be a valuable test in patients that in addition to 
one or more CA have developmental delay/intellectual disabil-
ity, behavioural problems and/or dysmorphia, establishing the 
diagnosis in 41.2% of patients.
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Intellectual disability/Developmental delays (ID/DD) are present 
in 2-3% of children and the worldwide population prevalence 
of autism spectrum disorder (ASD) is about 1%. Congenital 
anomalies (CA) are the leading cause of stillbirth and infant 
mortality and an important contributor to childhood morbidity. 
Over 130,000 children with CA are born in Europe each year. 
Their physical, mental and social handicaps are a significant 
burden on the healthcare, social and educational services. There-
fore, all these disorders are an important public health problem 
and a major diagnostic challenge, due to their complex etiology. 
To promote the research in this area, the project “Reproductive 
and Regenerative Medicine - Exploration of New Platforms and 
Potentials” of the Center of Excellence for Reproductive and 
Regenerative Medicine (CERRM), has set “Epigenetic Research 
of Genetic Disorders/Congenital Anomalies” as one of its topics. 
The target group patients consists of children with ID/DD, 
ASD, CA and rare neurodevelopmental disorders of unknown 
aetiology. The project will investigate the underlying genetic and 
epigenetic mechanisms, with special reference to genotype-phe-
notype correlation, opening up new ways of treatment and pre-
vention strategies, and application of genomics and epigenomics 
in the clinical practice. It is expected that the study will identify 
new epigenetic markers, candidate genes and pathogenic variants 
associated with conditions under study, establishing accurate 
genetic diagnosis that will allow genetic counseling, prenatal 
and preimplantation diagnosis and cascade screening of family 
members at risk. The research could open the way of finding 
new therapeutic options based on the epigenetic modification of 
targeted genome regions.
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Teratocarcinoma (TCa) is a type of mixed testicular germ cell 
tumor (TGCT) composed of teratoma and embryonal carcino-
ma. In 1970s Solter, Damjanov and Škreb discovered that TCa 
could be produced by transplanting gastrulating mouse embryos 
underneath a kidney capsule of a syngeneic animal. TCa was 
identified by classical histological analysis and now this experi-
mental mouse teratocarcinoma model is considered as suitable 
for studying TGCT biology. Molecular systematic analysis and 
comparison of human and mouse model TCa have not been per-
formed. The purpose of this research is to compare proliferative 
and apoptotic activity in human and mouse experimental TCa. 
For immunohistochemical detection of PCNA and Caspase-3 
expression, 20 human testicular teratocarcinoma and 14 experi-
mental mouse teratocarcinoma paraffin- embedded tissues were 
used. Slides were semi-quantitatively analyzed and results were 
categorised regarding percentage of IHC-positively stained cells 
as 0 (0%),1 (<10%), 2 (10-50%) and 3 (>50%). Differences in 
rates of proliferation and apoptosis between human and mouse 
TCa were statistically significant. Most of experimental mouse 
TCa (64%) and just 30% human TCa showed >50% PCNA- 
positively stained cells. With respect to Caspase-3 staining, 
mouse TCa samples were similarly distributed among categories 
1, 2 and 3 while 70% of human TCa belonged to category 1. 
Analysis of proliferation and apoptosis based on percentage 
of PCNA and Caspase-3 positively stained cells statistically 
significant differ between human and mouse experimental TCa. 
This result may be due to small and unequal number of samples. 
Further analysis should be done and we are planing to conduct 
Western blot analysis of PCNA and Caspase-3.
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Aiming to investigate changes in neuronal connectivity after 
perinatal hypoxic brain lesion, we were analyzed perineuronal 
nets and cognitive behavior in a new non-invasive model of 
brain injury in rats. Nineteen Wistar Han® (RccHan®:WIST) 
rats, (9 females and 10 males) were randomly divided into hy-
poxic and control group on postnatal day 1 (P1) when hypoxia 
was induced in a warm (≈ 25°C) hypobaric chamber (Atm 
350mmHg, pO273mmHg) during 2 hours, while controls were 
kept in normal housing conditions. Behavioral tests were per-
formed at P30 and P70 using the open field, hole board, social 
choice, and T-maze tests. Samples of brain tissue from adult 
animals (P105) were used for histochemical examination of the 
cytoarchitectonics (Nissl staining), interneurons (parvalbumin 
immunohistochemistry) and perineuronal nets (Wisteria flori-
bunda agglutinin, histochemistry). After mild perinatal hypoxic 
brain injury, cerebral cytoarchitectonics, as well as the laminar 
and structural organization of the telencephalon were preserved. 
However, changes in morphology, number, and distribution of 
the parvalbumin-immunoreactive neurons and perineuronal 
nets, distinct in different regions of the telencephalon, were 
observed. Moreover, motor and socialization patterns were 
preserved, while treated animals showed significantly impaired 
learning behavior. In conclusion, a short-term perinatal hypoxic 
brain injury in rats leads to disturbances in brain connectivity 
related to cognitive processes consistent through development 
and adulthood. Further characterization and evaluation of this 
brain injury model, on molecular, cytological and connectivity 
levels, is needed to disclose developmental disturbances caused 
by provoked hypoxia that are not compensated during develop-
ment and lead to cognitive deficits still present in adult rats.
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The Semaphorin-5A (Sema5A) is a transmembrane protein that 
has been shown to have a role as bifunctional axon guidance 
molecule during axon elongation and cell migration in the 
development of diencephalon and its connections. Mutations 
of Sema5A are linked to the etiology of some disorders and 
syndromes, as microdeletion of SEMA5A found in patients 
with autism spectrum and haploinsufficiency for SEMA5A in 
Cri-du-chat syndrome. We are lacking data on SEMA5A protein 
expression in human brain but according to the recent data (Al-
lan Brain Institute), the transcripts of Sema5A gene are present 
in proliferative zones of the developing telencephalon in rodents 
at age E13.5 E15.5 and P14.
In the present study, we used in vitro functional essay and 
post-mortem protein expression analysis to reveal possible role 
of Sema5A in mammalian brain development. The neocortical 
explants from mouse embryo (E15) were cultivated 72h on 
Sema5a uniform or alternately presenting carpet (made of mem-
brane homogenate of Sema5A transfected Human Embryonic 
Kidney 293 cells.)
Results of the in vitro study show that Sema5A promotes 
outgrowth and elongation of neocortical axons when uniformly 
presented on the carpet, but does not steer axons or modulate 
collateralization on Sema5A-alternating carpets. The expression 
of Sema5A protein revealed by immunohistochemical staining 
was more prominent at P15 than at P5 in the entire cortex 
with the clear regional differences in the expression. The most 
prominent change in expression was in somatosensory cortex 
suggesting a role of Sema5a in the development of the thalamo-
cortical connections and the area in the observed early postnatal 
period. Further postmortem studies are needed to get a better 
understanding of Sema5A interaction with specific proteoglycans 
in the extracellular matrix, which subsequently would lead to a 
disclosure of the Sema5A role in the development of the telen-
cephalon connectivity in health and disease.
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